Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 5:54 PM View:  | Wave Life Sciences Ltd. (WVE) | 27-Sep-24 | Purchase | 2,791,930 | $8.00 | $22,335,400.00 | 20% 13.98M to 16.78M | |
| 30-Jan-24 4:39 PM View: | Wave Life Sciences Ltd. (WVE) | 07-Dec-23 | Purchase | 3,300,000 | $5.00 | $16,500,000.00 | 31% 10.68M to 13.98M | |
| 20-Sep-22 4:16 PM View: | Theravance Biopharma, Inc. (TBPH) | 16-Sep-22 | Disposition (other) | 9,644,810 | $9.75 | $94,036,896.00 | (100%) 9.64M to 0 | < 1% |
| 06-Jul-21 10:00 PM View: | Cvrx, Inc. (CVRX) | 02-Jul-21 | Conversion | 700,772 | -- | -- | 92% 764.4K to 1.47M | |
| 06-Jul-21 10:00 PM View: | Cvrx, Inc. (CVRX) | 02-Jul-21 | Private Purchase | 275,000 | $18.00 | $4,950,000.00 | 19% 1.47M to 1.74M | |
| 23-Jun-21 6:14 PM View: | Lyell Immunopharma, Inc. (LYEL) | 21-Jun-21 | Conversion | 30,253,200 | -- | -- | 100% 0 to 30.25M | |
| 24-May-21 5:04 PM View: | Theravance Inc. (INVA) | 20-May-21 | Market Sale | 32,005,300 | $12.25 | $392,064,000.00 | (100%) 32.01M to 0 | (8%) |
| 19-Feb-21 4:50 PM View: | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Conversion | 1,033,660 | -- | -- | 100% 0 to 1.03M | |
| 19-Feb-21 4:50 PM View: | Decibel Therapeutics, Inc. (DBTX) | 17-Feb-21 | Purchase | 150,000 | $18.00 | $2,700,000.00 | 15% 1.03M to 1.18M | |
| 30-Jul-20 8:56 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jul-20 | Private Purchase | 1,260,500 | $2.25 | $2,836,130.00 | 37% 3.37M to 4.63M | |
| 22-Jul-20 4:18 PM View: | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion Duplicate | 1,887,190 | -- | -- | 100% 0 to 1.89M | |
| 22-Jul-20 4:18 PM View: | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase Duplicate | 361,111 | $18.00 | $6,500,000.00 | 19% 1.89M to 2.25M | |
| 18-Sep-20 12:04 PM View: | Bicycle Therapeutics Plc (BCYC) | 15-Jul-20 | Market Sale | 3,147 | $19.40 | $61,045.00 | (< 1%) 1.91M to 1.91M | (54%) |
| 16-Jul-20 8:13 PM View: | Nkarta, Inc. (NKTX) | 14-Jul-20 | Conversion | 2,317,400 | -- | -- | 2930% 79.09K to 2.4M | |
| 16-Jul-20 8:13 PM View: | Nkarta, Inc. (NKTX) | 14-Jul-20 | Purchase | 833,333 | $18.00 | $15,000,000.00 | 35% 2.4M to 3.23M | |
| 18-Sep-20 12:04 PM View: | Bicycle Therapeutics Plc (BCYC) | 14-Jul-20 | Market Sale | 1,597 | $19.27 | $30,780.60 | (< 1%) 1.92M to 1.91M | (55%) |
| 26-May-20 4:17 PM View: | Turning Point Therapeutics,... (TPTX) | 21-May-20 | Market Purchase | 83,333 | $60.00 | $4,999,980.00 | 4% 2.17M to 2.25M | 124% |
| 21-May-20 5:21 PM View: | Progyny, Inc. (PGNY) | 20-May-20 | Sale | 4,000,000 | $25.75 | $103,000,000.00 | (39%) 10.24M to 6.24M | |
| 31-Oct-19 6:27 PM View: | Progyny, Inc. (PGNY) | 29-Oct-19 | Conversion | 9,821,190 | -- | -- | 2355% 417.01K to 10.24M | |
| 22-Oct-19 5:36 PM View: | Principia Biopharma Inc. (PRNB) | 18-Oct-19 | Private Purchase Duplicate | 357,142 | $28.00 | $9,999,980.00 | 14% 2.63M to 2.98M | |
| 12-Sep-19 4:18 PM View: | Turning Point Therapeutics,... (TPTX) | 10-Sep-19 | Market Purchase Duplicate | 177,777 | $45.00 | $7,999,960.00 | 9% 1.99M to 2.17M | 199% |
| 24-Jul-19 4:01 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 22-Jul-19 | Conversion | 1,785,710 | -- | -- | 100% 0 to 1.79M | |
| 02-Jul-19 4:13 PM View: | Morphic Holding, Inc. (MORF) | 01-Jul-19 | Conversion Duplicate | 2,300,440 | -- | -- | 100% 0 to 2.3M | |
| 02-Jul-19 4:13 PM View: | Morphic Holding, Inc. (MORF) | 01-Jul-19 | Purchase Duplicate | 333,333 | $15.00 | $5,000,000.00 | 14% 2.3M to 2.63M | |
| 26-Jun-19 10:46 AM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jun-19 | Market Purchase | 1,857,140 | $3.50 | $6,500,000.00 | 123% 1.51M to 3.37M | (24%) |
| 30-May-19 5:47 PM View: | Bicycle Therapeutics Plc (BCYC) | 28-May-19 | Conversion Duplicate | 1,529,560 | -- | -- | 100% 0 to 1.53M | |
| 30-May-19 5:47 PM View: | Bicycle Therapeutics Plc (BCYC) | 28-May-19 | Purchase | 385,714 | $14.00 | $5,400,000.00 | 25% 1.53M to 1.92M | |
| 24-Apr-19 7:28 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Apr-19 | Conversion Duplicate | 1,667,550 | -- | -- | 100% 0 to 1.67M | |
| 24-Apr-19 7:28 PM View: | Turning Point Therapeutics,... (TPTX) | 22-Apr-19 | Purchase Duplicate | 325,000 | $18.00 | $5,850,000.00 | 19% 1.67M to 1.99M | |
| 18-Oct-18 5:03 PM View: | ChemoCentryx, Inc. (CCXI) | 16-Oct-18 | Market Sale | 7,343,490 | $11.69 | $85,845,400.00 | (100%) 7.34M to 0 | 11% |
| 20-Sep-18 5:18 PM View: | Principia Biopharma Inc. (PRNB) | 18-Sep-18 | Conversion | 2,355,710 | -- | -- | 100% 0 to 2.36M | |
| 20-Sep-18 5:18 PM View: | Principia Biopharma Inc. (PRNB) | 18-Sep-18 | Purchase Duplicate | 270,000 | $17.00 | $4,590,000.00 | 11% 2.36M to 2.63M | |
| 01-Aug-18 6:32 PM View: | Liquidia Technologies Inc (LQDA) | 30-Jul-18 | Conversion | 455,111 | -- | -- | 2221% 20.49K to 475.6K | |
| 01-Aug-18 6:32 PM View: | Liquidia Technologies Inc (LQDA) | 30-Jul-18 | Purchase | 148,818 | $11.00 | $1,637,000.00 | 31% 475.6K to 624.42K | |
| 17-Jul-18 5:01 PM View: | Spero Therapeutics, Inc. (SPRO) | 17-Jul-18 | Purchase | 80,000 | $12.50 | $1,000,000.00 | 4% 1.85M to 1.93M | |
| 03-Jul-18 5:59 PM View: | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Conversion | 3,428,680 | -- | -- | 100% 0 to 3.43M | |
| 03-Jul-18 5:59 PM View: | Translate Bio, Inc. (TBIO) | 02-Jul-18 | Purchase | 269,230 | $13.00 | $3,499,990.00 | 8% 3.43M to 3.7M | |
| 07-Nov-17 7:42 PM View: | Spero Therapeutics, Inc. (SPRO) | 06-Nov-17 | Conversion Duplicate | 1,425,440 | -- | -- | 100% 0 to 1.43M | |
| 07-Nov-17 7:42 PM View: | Spero Therapeutics, Inc. (SPRO) | 06-Nov-17 | Purchase Duplicate | 428,571 | $14.00 | $5,999,990.00 | 30% 1.43M to 1.85M | |
| 29-Mar-17 4:04 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 27-Mar-17 | Market Sale | 300,000 | $10.15 | $3,045,180.00 | (27%) 1.09M to 792.78K | 97% |
| 26-Oct-16 5:49 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Conversion | 3,154,130 | -- | -- | 100% 0 to 3.15M | |
| 26-Oct-16 5:49 PM View: | Crispr Therapeutics Ag (CRSP) | 24-Oct-16 | Purchase | 66,500 | $14.00 | $931,000.00 | 2% 3.15M to 3.22M | |
| 15-Mar-16 4:31 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Mar-16 | Purchase | 1,301,020 | $23,028,000.00 | $29,959,699,562,496.00 | 16% 8.34M to 9.64M | |
| 07-Oct-15 4:31 PM View: | Theravance Biopharma, Inc. (TBPH) | 07-Oct-15 | Purchase | 44,574 | $607,544.00 | $27,080,599,552.00 | < 1% 8.3M to 8.34M | |
| 07-Aug-15 4:18 PM View: | Theravance Inc. (INVA) | 07-Aug-15 | Purchase | 245,828 | $3,485,840.00 | $856,917,016,576.00 | < 1% 31.76M to 32.01M | |
| 11-May-15 3:40 PM View: | Theravance Inc. (INVA) | 11-May-15 | Purchase | 85,579 | $1,369,260.00 | $117,179,998,208.00 | < 1% 31.67M to 31.76M | |
| 13-May-15 12:36 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 11-May-15 | Conversion | 592,866 | -- | -- | 100% 0 to 592.87K | |
| 13-May-15 12:36 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 11-May-15 | Acquisition (other) | 91,271 | -- | -- | 15% 592.87K to 684.14K | |
| 13-May-15 12:36 PM View: | Htg Molecular Diagnostics, ... (HTGM) | 11-May-15 | Purchase Duplicate | 365,106 | $14.00 | $5,111,480.00 | 53% 684.13K to 1.05M | |
| 02-Mar-15 3:45 PM View: | Theravance Inc. (INVA) | 02-Mar-15 | Purchase | 92,674 | $1,673,690.00 | $155,107,999,744.00 | < 1% 31.58M to 31.67M |